197 related articles for article (PubMed ID: 2642711)
1. High resolution 1H-NMR studies of Des-(B26-B30)-insulin; assignment of resonances and properties of aromatic residues.
Hua QX; Chen YJ; Wang CC; Wang DC; Roberts GC
Biochim Biophys Acta; 1989 Feb; 994(2):114-20. PubMed ID: 2642711
[TBL] [Abstract][Full Text] [Related]
2. 1H n.m.r. studies of insulin. Assignment of resonances and properties of tyrosine residues.
Bradbury JH; Ramesh V
Biochem J; 1985 Aug; 229(3):731-7. PubMed ID: 3902004
[TBL] [Abstract][Full Text] [Related]
3. Sequence-specific 1H-NMR assignments for the aromatic region of several biologically active, monomeric insulins including native human insulin.
Roy M; Lee RW; Kaarsholm NC; Thøgersen H; Brange J; Dunn MF
Biochim Biophys Acta; 1990 Jun; 1053(1):63-73. PubMed ID: 2194578
[TBL] [Abstract][Full Text] [Related]
4. The solution structure of a monomeric insulin. A two-dimensional 1H-NMR study of des-(B26-B30)-insulin in combination with distance geometry and restrained molecular dynamics.
Knegtel RM; Boelens R; Ganadu ML; Kaptein R
Eur J Biochem; 1991 Dec; 202(2):447-58. PubMed ID: 1761045
[TBL] [Abstract][Full Text] [Related]
5. Semisynthetic des-(B27-B30)-insulins with modified B26-tyrosine.
Lenz V; Gattner HG; Sievert D; Wollmer A; Engels M; Höcker H
Biol Chem Hoppe Seyler; 1991 Jul; 372(7):495-504. PubMed ID: 1930732
[TBL] [Abstract][Full Text] [Related]
6. Extending Halogen-based Medicinal Chemistry to Proteins: IODO-INSULIN AS A CASE STUDY.
El Hage K; Pandyarajan V; Phillips NB; Smith BJ; Menting JG; Whittaker J; Lawrence MC; Meuwly M; Weiss MA
J Biol Chem; 2016 Dec; 291(53):27023-27041. PubMed ID: 27875310
[TBL] [Abstract][Full Text] [Related]
7. Comparative 2D NMR studies of human insulin and des-pentapeptide insulin: sequential resonance assignment and implications for protein dynamics and receptor recognition.
Hua QX; Weiss MA
Biochemistry; 1991 Jun; 30(22):5505-15. PubMed ID: 2036420
[TBL] [Abstract][Full Text] [Related]
8. Two-dimensional NMR studies on des-pentapeptide-insulin. Proton resonance assignments and secondary structure analysis.
Boelens R; Ganadu ML; Verheyden P; Kaptein R
Eur J Biochem; 1990 Jul; 191(1):147-53. PubMed ID: 2199196
[TBL] [Abstract][Full Text] [Related]
9. High-resolution structure of an engineered biologically potent insulin monomer, B16 Tyr-->His, as determined by nuclear magnetic resonance spectroscopy.
Ludvigsen S; Roy M; Thøgersen H; Kaarsholm NC
Biochemistry; 1994 Jul; 33(26):7998-8006. PubMed ID: 8025104
[TBL] [Abstract][Full Text] [Related]
10. Shortened insulin analogues: marked changes in biological activity resulting from replacement of TyrB26 and N-methylation of peptide bonds in the C-terminus of the B-chain.
Záková L; Barth T; Jirácek J; Barthová J; Zórad S
Biochemistry; 2004 Mar; 43(8):2323-31. PubMed ID: 14979729
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of an engineered insulin monomer at neutral pH.
Olsen HB; Ludvigsen S; Kaarsholm NC
Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationships of des-(B26-B30)-insulin.
Spoden M; Gattner HG; Zahn H; Brandenburg D
Int J Pept Protein Res; 1995; 46(3-4):221-7. PubMed ID: 8537175
[TBL] [Abstract][Full Text] [Related]
13. Two-dimensional NMR studies of Des-(B26-B30)-insulin: sequence-specific resonance assignments and effects of solvent composition.
Hua QX; Weiss MA
Biochim Biophys Acta; 1991 May; 1078(1):101-10. PubMed ID: 1646635
[TBL] [Abstract][Full Text] [Related]
14. H spin system identifications of S-sulfonated insulin B chain with 2D-NMR.
Hua QX
Sci China B; 1989 Aug; 32(8):948-59. PubMed ID: 2692597
[TBL] [Abstract][Full Text] [Related]
15. Assignment of the aromatic 1H-NMR resonances of myotoxin a isolated from the venom of Crotalus viridis viridis.
Henderson JT; Nieman RA; Bieber AL
Biochim Biophys Acta; 1987 Aug; 914(2):152-61. PubMed ID: 3607069
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of the aromatic amino acid residues in the globular conformation of the basic pancreatic trypsin inhibitor (BPTI). I. 1H NMR studies.
Wagner G; DeMarco A; Wüthrich K
Biophys Struct Mech; 1976 Aug; 2(2):139-58. PubMed ID: 9165
[TBL] [Abstract][Full Text] [Related]
17. In vivo metabolic activity of des-(B26-B30)-insulin-B25-amide and related analogues in the rat.
Stümpel F; Hartmann H; Brandenburg D; Creutzfeldt W
Diabetes Res Clin Pract; 1990 Jul; 9(3):257-64. PubMed ID: 2226126
[TBL] [Abstract][Full Text] [Related]
18. Two-dimensional NMR and photo-CIDNP studies of the insulin monomer: assignment of aromatic resonances with application to protein folding, structure, and dynamics.
Weiss MA; Nguyen DT; Khait I; Inouye K; Frank BH; Beckage M; O'Shea E; Shoelson SE; Karplus M; Neuringer LJ
Biochemistry; 1989 Dec; 28(25):9855-73. PubMed ID: 2692717
[TBL] [Abstract][Full Text] [Related]
19. Role of the phenylalanine B25 side chain in directing insulin interaction with its receptor. Steric and conformational effects.
Nakagawa SH; Tager HS
J Biol Chem; 1986 Jun; 261(16):7332-41. PubMed ID: 3519607
[TBL] [Abstract][Full Text] [Related]
20. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant.
Záková L; Brynda J; Au-Alvarez O; Dodson EJ; Dodson GG; Whittingham JL; Brzozowski AM
Biochemistry; 2004 Dec; 43(51):16293-300. PubMed ID: 15610023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
